Monte Rosa Therapeutics Inc
XNAS:GLUE 4:00:00 PM EDT
| Market Cap (Intraday) | 973.42M |
| Current PE | 46.47 |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $16.02 |
| 50-Day MA | $14.86 |
| 200-Day MA | $7.73 |
Monte Rosa Therapeutics Inc Stock, XNAS:GLUE
321 Harrison Avenue, Suite 900, Boston, Massachusetts 02118
United States of America
Phone: +1.617.949.2643
Number of Employees: 133
Description
Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.